GlassScriptPhysician profile
Kaylee M Runge
NPI 1114686011
$1,122.87
in general payments reported to CMS, 2019-2025
16 companies · $308 in 2025
The $308 reported for 2025 was more than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $212 · 2023: $394 · 2024: $209 · 2025: $308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $911.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $328.94 | 2022-2024 | |
| Janssen Biotech, INC. | $154.01 | 2023-2025 | Stelara, Tecvayli, Carvykti |
| Geron Corporation | $134.76 | 2025 | Rytelo |
| Ferring Pharmaceuticals INC. | $124.13 | 2023 | Rebyota |
| Janssen Scientific Affairs, LLC | $90.30 | 2022 | |
| Celgene Corporation | $71.86 | 2024-2025 | Breyanzi |
| Pharmaessentia USA Corporation | $37.76 | 2024-2025 | Besremi |
| Genzyme Corporation | $24.23 | 2025 | |
| Beigene USA, INC. | $22.65 | 2024 | Brukinsa |
| Rigel Pharmaceuticals, INC. | $20.86 | 2024 | Rezlidhia, Tavalisse |
| Organon LLC | $20.71 | 2025 | Nexplanon |
| Adc Therapeutics America, INC. | $20.25 | 2024 | |
| Syndax Pharmaceuticals, INC. | $19.95 | 2025 | |
| Genentech USA, INC. | $18.22 | 2024 | Venclexta |
| Novartis Pharmaceuticals Corporation | $17.18 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $17.06 | 2024 | Xospata |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaylee Runge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.